Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1997
The drug in this study is combined product of biphenyl dimethyl dicarboxylate (DDB) and garlic oil. This components showed synergistic enhancing effects in previous tests. In phase 2 test, 6 cap three times a day dosage (2cap T.I.D) is better than other dosage. Based on above, this study is phase 3 test to prove efficacy and safety of PENNEL.
Epistemonikos ID: 45065e49780886de498e368763ebc7d2dc297123
First added on: May 06, 2024